Installation of MiaSole’s Solar Modules at ProLogis’ PV Test Site in Colorado

MiaSolé, the leading manufacturer of copper indium gallium selenide (CIGS) thin-film photovoltaic solar panels, today announced its participation and installation of MiaSolé modules at ProLogis Renewable Energy’s rooftop photovoltaic test site in Denver, Colorado.

MiaSolé modules

“Continued improvements in conversion efficiencies, manufacturing yields, and cost reductions have helped make photovoltaic solar one of the most affordable and efficient types of renewable energy today” said Joe Laia, CEO of MiaSolé. “We are pleased to participate in the ProLogis test site to demonstrate that our distinct manufacturing process produces CIGS modules that offer a compelling value to our customers.”

The ProLogis test site will provide side-by-side comparisons of modules from eight solar manufacturers. The site will measure the performance of a variety of module technologies, including thin film, monocrystalline, glass-on-glass and membrane-applied thin film modules.

The ProLogis Rooftop Photovoltaic test site marks the first Colorado project for MiaSolé and is the seventh testing facility in the United States to feature MiaSolé’s modules.

"MiaSolé and ProLogis share a common goal of expansion for large-scale distributed solar installations," said Laia. "We commend ProLogis's commitment to renewable energy and are proud to partner with them on this initiative."

MiaSole will have shipped 6.5MW in the first half of this year and expects to ship 22MW in 2010. MiaSolé’s CIGS thin-film photovoltaic solar panels currently convert 10.5% of sunlight into electricity. The products are designed specifically for large-scale rooftop and ground mount installations for utilities, independent power providers and industrial scale deployments.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.